ClinicalTrials.Veeva

Menu

Randomized Clinical Trial Comparing Short Versus Long Oesophageal Myotomy in POEM for Achalasia Cardia.

A

Asian Institute of Gastroenterology, India

Status

Completed

Conditions

Achalasia Cardia

Treatments

Procedure: Per oral endoscopic myotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03186248
AIG- 09/05

Details and patient eligibility

About

Aim of this study is to compare the outcomes of a short esophageal myotomy extending from 3 cm cephalad to the EGJ, to 3 cm distal to it with a long esophageal myotomy with an additional proximal extension (at least 6 cm cephalad to the EGJ, to 3 cm distal) for POEM procedures. Principle of POEM is to reduce pressure gradient across LES by Myotomy. Hypothesis is that performing short myotomy will result in similar efficacy in achalasia cardia while reducing the total time taken for the procedure and ultimately will result in less complications.

Full description

The primary goal of treatment of achalasia cardia (either LHM or POEM) is to divide the muscle at LES to reduce the pressure so that food bolus can pass down into the esophagus. However, there is little evidence regarding the optimal length of this myotomy for either procedure. During LHM the proximal length of myotomy is extended upto 6-8 cm in esophagus and distally to 3 cm in stomach. There are no data on long term outcomes between differential proximal myotomy lengths. The conventionally the esophageal myotomy is extended to 6-8 cm, this is based on technical considerations, as it is the maximum length that can safely be achieved via a laparoscopic, transhiatal approach. High pressure zone of Esophago gastric junction (EGJ) complex extends for 4 cm on an average with 2 cm on esophageal side. It is hypothesized that If shorter proximal myotomy that ablates just the EGJ complex could achieve the same normalization of EGJ physiology as a longer one, there could be several advantages to this modification. It will take less mediastinal dissection of the esophagus, potentially reducing the chances of esophageal perforation, vagal injury and pleural tears. During POEM, a shorter myotomy would allow for creation of a shorter submucosal tunnel, decreasing operative time along with potentially decreasing the incidence of mucosal perforations, pneumothorax and pneumoperitoneum. Additionally, there is chance that many patients regain some esophageal peristalsis after both LHM and POEM. Patients undergoing POEM for type 1 and type 2 Achalasia cardia will be randomised into 2 groups of short oesophageal (3 cm) and long oesophageal ( 6-8 cm) myotomy.

Enrollment

71 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Type 1 and 2 achalasia with eckerd score >3 (0-12 scale achalasia) -.
  2. Age 18-75 years.
  3. Treatment naïve or history of pneumatic balloon dilatation.
  4. Willing and able to comply with the study procedures and provide written informed consent form to participate in the study.

Exclusion criteria

  1. Type 3 achalasia cardia or any other esophageal motility disorder
  2. Previous surgery of the esophagus or stomach
  3. Active severe esophagitis
  4. Large lower esophageal diverticula
  5. Large > 3cm hiatal hernia
  6. Sigmoid esophagus
  7. Known gastroesophageal malignancy
  8. Inability to tolerate sedated upper endoscopy due to cardiopulmonary instability, severe pulmonary disease or other contraindication to endoscopy
  9. Cirrhosis with portal hypertension, varices, and/or ascites

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

71 participants in 2 patient groups

Short myotomy
Experimental group
Description:
Per oral endoscopic myotomy extending from 3 cm cephalad to 3 cm distal to EGJ
Treatment:
Procedure: Per oral endoscopic myotomy
Long myotomy
Active Comparator group
Description:
Per oral endoscopic myotomy extending from 6-8cm cephalad to and 3 cm distal to EGJ.
Treatment:
Procedure: Per oral endoscopic myotomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems